Page 2 - Rodney Varner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a.

United statesGenentech tecentriqMark bergerKalyn dabbsRodney varnerExchange commissionDrug administrationGenprex incPrnewswire genprex incCompany websiteExpands clinical trial sitesTreat small cell lungFast trackImmunogene therapyChief executive officerChief medical officer

Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing the Company's non-viral Oncoprex® Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer (NSCLC) in a humanized mouse model.

Kalyn dabbsRodney varnerGenprex oncoprexCompany websiteGenprex incExchange commissionDelivery systemChief executive officerImmunogene therapyNatural killerFast track designationLanguage concerning forward looking statementsPrivate securities litigation reform actAnnual reportNasdaq capital market

Genprex: Collaborators Report Positive Preclinical Data With NPRL2 Gene Therapy

Genprex, Inc. (GNPX) reported that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing the non-viral Oncoprex Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer in a humanized mouse model.

Rodney varnerMore such health newsGenprex incOncoprex delivery systemHumanized mouseChief executive officer

BioMedNewsBreaks – Genprex Inc (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy

BioMedNewsBreaks – Genprex Inc (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesReqorsar immunogeneRodney varnerLife sciencesGenprex incBiomedical sciences biomedDelivery systemImmunogene therapyFast track designationBiomedical sciencesDynamic brand portfolioPhones only

BioMedNewsBreaks – Genprex Inc (NASDAQ: GNPX) Announces New Research Collaborations, Expansion of Nonclinical Programs into New Therapeutic Indications

BioMedNewsBreaks – Genprex Inc (NASDAQ: GNPX) Announces New Research Collaborations, Expansion of Nonclinical Programs into New Therapeutic Indications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoRodney varnerReqorsar immunogeneLife sciencesMeharry medical collegeRogel cancer centerUniversity of michiganGenprex incBiomedical sciences biomedDrug administrationDelivery systemImmunogene therapyBiomedical sciencesDynamic brand portfolioPhones only